Chemical Component Summary

NameSTAUROSPORINE
Identifiers
FormulaC28 H26 N4 O3
Molecular Weight466.53
TypeNON-POLYMER
Isomeric SMILESCN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35
InChIInChI=1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1
InChIKeyHKSZLNNOFSGOKW-FYTWVXJKSA-N

Chemical Details

Formal Charge0
Atom Count61
Chiral Atom Count4
Bond Count68
Aromatic Bond Count24

Drug Info: DrugBank

DrugBank IDDB02010 
NameStaurosporine
Groupsexperimental
DescriptionAn indolocarbazole that is a potent protein kinase C inhibitor which enhances cAMP-mediated responses in human neuroblastoma cells. (Biochem Biophys Res Commun 1995;214(3):1114-20)
SynonymsStaurosporine
Categories
  • Alkaloids
  • Carbazoles
  • Enzyme Inhibitors
  • Heterocyclic Compounds, Fused-Ring
  • Indole Alkaloids
CAS number62996-74-1

Drug Targets

NameTarget SequencePharmacological ActionActions
Tyrosine-protein kinase LckMGCGCSSHPEDDWMENIDVCENCHYPIVPLDGKGTLLIRNGSEVRDPLVT...unknown
Serine/threonine-protein kinase pim-1MPHEPHEPLTPPFSALPDPAGAPSRRQSRQRPQLSSDSPSAFRASRSHSR...unknown
Tyrosine-protein kinase ITK/TSKMNNFILLEEQLIKKSQQKRRTSPSNFKVRFFVLTKASLAYFEDRHGKKRT...unknown
Tyrosine-protein kinase SYKMASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGG...unknown
MAP kinase-activated protein kinase 2MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKS...unknown
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682